abstract |
More than 15% w / w of the compound of formula (I) and / or its hydrate as defined herein and an amount of one or more sufficient to provide sufficient in vitro dissolution Pharmaceutical compositions comprising a foaming agent and further comprising one or more pharmaceutically acceptable ingredients, as well as methods for obtaining the same are provided. |